Literature DB >> 12532024

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Chandrashekhar Pasare1, Ruslan Medzhitov.   

Abstract

Toll-like receptors (TLRs) control activation of adaptive immune responses by antigen-presenting cells (APCs). However, initiation of adaptive immune responses is also controlled by regulatory T cells (TR cells), which act to prevent activation of autoreactive T cells. Here we describe a second mechanism of immune induction by TLRs, which is independent of effects on costimulation. Microbial induction of the Toll pathway blocked the suppressive effect of CD4+CD25+ TR cells, allowing activation of pathogen-specific adaptive immune responses. This block of suppressor activity was dependent in part on interleukin-6, which was induced by TLRs upon recognition of microbial products.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532024     DOI: 10.1126/science.1078231

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  670 in total

1.  Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism.

Authors:  Alicia Benson; Sean Murray; Prashanthi Divakar; Nikolay Burnaevskiy; Reed Pifer; James Forman; Felix Yarovinsky
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

2.  Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.

Authors:  Shenghe Tian; Zuqiang Liu; Cara Donahue; Louis D Falo; Zhaoyang You
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

3.  Costimulatory signals controlling regulatory T cells.

Authors:  Joerg Ermann; C Garrison Fathman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

Review 4.  Regulation of granulomatous inflammation in experimental models of schistosomiasis.

Authors:  Abram B Stavitsky
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 5.  Immune therapies.

Authors:  Rao H Prabhala; Nikhil C Munshi
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

6.  IL-17-producing human peripheral regulatory T cells retain suppressive function.

Authors:  Gaëlle Beriou; Cristina M Costantino; Charles W Ashley; Li Yang; Vijay K Kuchroo; Clare Baecher-Allan; David A Hafler
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

7.  Enhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.

Authors:  Scott N Furlan; Rajakumar Mandraju; Travis Brewer; Kole Roybal; Ty Dale Troutman; Wei Hu; Noah W Palm; Arun Unni; Chandrashekhar Pasare
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 8.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

Review 9.  Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages.

Authors:  B Kelsall
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

10.  Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells.

Authors:  Dominik Schenten; Simone A Nish; Shuang Yu; Xiting Yan; Heung Kyu Lee; Igor Brodsky; Lesley Pasman; Brian Yordy; F Thomas Wunderlich; Jens C Brüning; Hongyu Zhao; Ruslan Medzhitov
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.